James Healy, Director, 10% Owner at CinCor Pharma, Inc. (CINC), bought 506,000 shares at $30.00 ($15.2M) on 2022-08-11, disclosed to the SEC on 2022-08-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 6,000 | $180K | 1.2% |
| 2 | $30.00 | 500,000 | $15.0M | 98.8% |
| Total | $30.00 avg | 506,000 | $15.2M | 100% |
| Filing → |
| RAPP | BUY | 2024-06-10 | $9.5M | — | Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |